Effect of Water Intake on the DNA Adducts Formation

NCT ID: NCT01583387

Last Updated: 2016-10-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

65 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-02-28

Study Completion Date

2011-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main purpose of the study is to assess the effect of water intake on the formation of 4-ABP DNA adducts.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Adults

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1= Intervention

Group Type OTHER

1-Increased water intake regimen

Intervention Type OTHER

Arm 1-Intervention

2= Control

Group Type OTHER

2-Non-modified water intake regimen

Intervention Type OTHER

Arm 2-Control

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

1-Increased water intake regimen

Arm 1-Intervention

Intervention Type OTHER

2-Non-modified water intake regimen

Arm 2-Control

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male subjects 20 to 45 years old (bound included)
* Smoker with at least 15 cigarettes/day
* Subjects with body mass index between 18 and 27kg/m2 (bound included)
* Subjects with a 3-meal diet (breakfast, lunch, dinner)
* Subjects who have an easy daily access to internet
* Subjects able to communicate well with the investigator and willing to comply the requirement of the study
* Subjects who have signed the form of informed consent and are registered to the French national welfare system

Exclusion Criteria

* Subjects presenting evidence or history of severe or acute disease which could affect the results of the study or the vital status
* Subject practising physical activity in an intensive way according to the investigator judgment.
* Subject with a history of metabolic disease or with acute or chronic gastrointestinal disease except appendicectomy
* Subjects with diagnosed urinary tract disease
* Subjects with diagnosed lung or respiratory disease
* Subjects consuming regularly more than 3 units of alcohol per day
* Subjects who take drugs or presenting drug addiction (cannabis, opioids, amphetamines.)
* Subjects presenting a situation interfering with the outcomes of the study according to the investigator opinion
* Subjects working with painting, dry cleaning, dyes, pesticides, aluminium or alphalt
* Subjects who eat charcoaled food more than three meals/week
* Subjects with a vegetarian diet
* Subjects under local or general treatment which can modify measurements performed in the study, in particular the assessment of the hydration status (diuretic intake, or treatment interfering with metabolism and nutrition behaviour)
* Subjects planning to stop or reducing smoking or change their cigarette brand within the next 3 months
* Subjects in a situation which in the investigator's opinion could interfere with optimal participation in the present study or could constitute a special risk for the subject
* Subjects currently in a exclusion period following participation in another clinical trial
* Subjects having received 4500 euros indemnities for participation in clinical trials in the 12 previous months (including participation in the present study)
Minimum Eligible Age

20 Years

Maximum Eligible Age

45 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Danone Global Research & Innovation Center

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre CAP

Montpellier, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NU340

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Body's Affect on Vitamin C
NCT00001309 COMPLETED PHASE1
Coffee and In-vivo Oxidative Stress
NCT00868205 COMPLETED PHASE2
Astringency and Oral Health
NCT05819073 COMPLETED NA
Caffeine, DNA and Cognition
NCT05806476 UNKNOWN NA